Research

Hormone Therapy Can Alter Blood Pressure in Transgender Individuals

April 20, 2021

Data from a pair of Washington, DC-based medical centers are providing an overview of the impact gender-affirming hormone therapy can have on blood pressure in transgender individuals.

DOACs May be More Effective than Warfarin for Valvular AFib

March 30, 2021

An analysis of claims data by investigators at University of Pennsylvania indicates DOACs were associated with a 36% lower risk of stroke or systemic embolism and was also associated with a reduction in risk of major bleeding.

Patient-Reported Outcomes Best NYHA Class for Capturing Progression of Heart Failure

March 25, 2021

An analysis of more than 2k HFrEF patients from the CHAMP-HF registry indicates changes in KCCQ-OS may be a more accurate way of capturing changes in disease state than New York Heart Association class.

Transgender Youth at Risk of Adverse Cardiometabolic Health, ENDO 2021 Study Finds

March 22, 2021

An analysis comparing propensity-matched data from 4k transgender is providing an updated overview of the risk profile for patients undergoing gender-affirming therapy compared to their cisgender counterparts.

Abdominal Aortic Calcification Tied to 80% Increase in Risk of CV Events, Death

January 18, 2021

Results from a systematic review and meta-analysis of more than 50 studies assessing cardiovascular risk with levels of abdominal aortic calcification indicate increased AAC was linked to 80% increase in risk of cardiovascular events and cardiovascular death.

Proximity to Fracking Activity Linked to Increased Risk of Heart Failure Hospitalization

December 09, 2020

An analysis of data from Geisinger suggests living closer to fracking activity could increase a person's risk of hospitalization for heart failure.

ACURATE neo Valve Fails to Demonstrate NonInferiority vs CoreValve Evolut in SCOPE II

October 19, 2020

Results of the SCOPE II trial from TCT Connect offer insight into the head-to-head comparison of ACURATE neo valve versus the CoreValve Evolut R System.

Crushed Prasugrel Prior to PCI Provides No Reperfusion Benefit in STEMI Patients

October 15, 2020

A trial presented at TCT 2020 suggests crushed prasugrel provided no reperfusion benefit when compared against integral tablet in STEMI patients.

Analysis of SGLT2 Inhibitor Outcomes Trials Details Cardiovascular, Renal Benefits

October 11, 2020

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

Gregory Weiss, MD: Has the Time Come for a Cardiometabolic Subspecialty?

October 02, 2020

Gregory Weiss, MD, reflects on the idea of creating a cardiometabolic subspecialty.